Virtual Reality to deal with Post traumatic stress disorder: Interview with Todd Richmond, Director of USC’s Mixed Reality Lab

While Post traumatic stress disorder is really a major problem for a lot of of individuals serving within the military yet others who operate in traumatic situations, additionally, it affects huge figures of ordinary individuals who experience traumatic occasions for example assaults or disasters. Nearly 24 million Americans are afflicted by Post traumatic stress disorder at any time, and ladies are two times as likely as men to build up the problem. Post traumatic stress disorder can often be overlooked and it is apparently underdiagnosed, but panic disorders still cost society roughly $40 billion each year in treatment costs and lack of productivity.

A comparatively new choice for Post traumatic stress disorder therapy involves virtual reality, with the aim of creating multisensory, immersive environments and encounters to deal with the problem. The process could be controlled with a clinician to match a patient’s needs, and also the results to date are promising.

Medgadget had the chance to inquire about Todd Richmond, Director from the Mixed Reality Lab in the College of Southern California and IEEE Member, some questions regarding the idea of using VR for Post traumatic stress disorder and just how it’s labored to date.

Conn Hastings, Medgadget: Do you know us the way you grew to become interested and involved in this region?

Todd Richmond, College of Los Angeles: In early stages within my chemistry faculty career I started while using web along with other digital media within my teaching and research. That motivated me to resign my faculty position in 2000, where I dove mind on into emerging tech. That brought me to USC, where I’ve been since in a number of positions – I’m now in the Institute for Creative Technologies (ICT), where I mind the Mixed Reality Lab.  I additionally function as research faculty in the School for Motion picture Arts.

I’ve been employed in many forms of digital media — mostly as put on training and learning — in excess of two decades. The strength of these platforms has elevated considerably during the last decade approximately, and extensions into day-to-day existence across all sectors have evolved rapidly. Within the medical area, two colleagues of mine happen to be inspirational to utilize. First is Dr. Skip Rizzo, that has pioneered using VR for the treatment of Post traumatic stress disorder at ICT. He is experienced within the field, and has worked with VR in clinical settings for many years.

Second is Dr. Leslie Saxon, who’s a cardiologist with USC Keck Med school, and who heads the USC Body Computing Center, that is co-found at ICT. I’ve labored with Leslie for several years, and she or he is really a pressure of nature, working towards better health outcomes by using body sensors, big data, Virtual, Augmented and Mixed Reality (VAMR), along with other emerging technologies.

Medgadget: Beyond Post traumatic stress disorder, what kinds of conditions is virtual reality useful for?

Todd Richmond: An organization in the College of Washington has witnessed encouraging results using VR for the treatment of discomfort in burn patients (distraction therapy). VR supports the commitment of treating numerous mental issues for example acrophobia [anxiety about heights] (and actually many phobias), anxiety, and depression, in addition to Alzheimer’s and dementia.

Medgadget: Are you able to talk us with the technology as put on Post traumatic stress disorder? Will the patient put on a headset? Exactly what do they see and experience?

Todd Richmond: With Skip’s system, the Medical VR experience happens inside a clinical setting having a trained clinician (psychiatrist/counselor) present. The individual wears a VR headset, and also the clinician includes a computer interface where they are able to pick the patient’s location (typically Iraq or Afghanistan, given the newest conflicts), time, weather, and scenario. The clinician may then see exactly what the patient sees on the application.

Because the patient describes the traumatic event, the clinician can recreate the scenario for that patient to “relive” and sort out. The protocol follows established operate in exposure therapy, and, obviously, the clinician doesn’t just jump into an overpowering entertainment – rather, the individual works to the traumatic occasions with time, just like they’d with no VR. VR exposure therapy provides two major benefits – the very first is for that patient, as they possibly can become more immersed within their past occasions, which will help these to confront and sort out them.

The 2nd, and possibly more essential, is perfect for the clinician. Because the patient describes the problem and also the clinician visually/aurally recreates it, they may have a better knowledge of exactly what the patient experienced. As the saying goes, an image may be worth a 1000 words – as well as an immersive VR scenario may be worth much more words.

You should observe that Medical VR isn’t a “doc inside a box” fix. The machine is made for carefully controlled clinical settings having a mental doctor.

Medgadget: Just how can a clinician tailor the therapy for any specific patient?

Todd Richmond: The clinician includes a “clinician’s control center” of sorts, which enables these to “point-and-click” to produce a multitude of scenarios with various stimuli, situations, and much more.

Medgadget: How has got the system labored for Post traumatic stress disorder patients to date?

Todd Richmond: Studies have proven significant enhancements in nearly all patients. Although this is not really a “silver bullet,” as they say, VR exposure treatments are showing to become a effective tool that medical professionals may use aid healing individuals who are suffering from Post traumatic stress disorder.

Link: Mixed Reality Lab in the College of Southern California…

First Digital Camera for Opioid Withdrawal Therapy Approved by Food and drug administration


The Food and drug administration has provided a regulatory eco-friendly light towards the first device that reduces opioid withdrawal signs and symptoms. The NSS-2 Bridge from Innovative Health Solutions, a Versailles, Indiana firm, is stuck towards the skin behind the ear and depends on four electrodes which are attached round the ear. The electrodes are utilized to deliver electric energy to some occipital and cranial nerves (V, VII, IX, and X), hopefully helping addicts to prevent agitation, insomnia, along with other signs and symptoms of kicking opioids. Exactly the same device was authorized by the Food and drug administration 3 years ago to be used in acupuncture and also the current approval went under the de novo review process meant for distinctively new low to moderate risk technologies.


The Food and drug administration based its decision on the study involving 73 patients which were experiencing physical signs and symptoms of withdrawal. Before while using NSS-2 Bridge, the topics had an average clinical opiate withdrawal scale (COWS) score of 20.1 (the greater, the more serious the signs and symptoms). While using device, the topics had a decrease in the COWS score by a minimum of 31% within 30 minutes of therapy activation. Furthermore, 64 from the 73 patients switched to medication aided therapy after 5 days of utilizing the NSS-2 Bridge.

The unit needs a prescription and isn’t supposed to have been utilized by patients using pacemakers or that suffer from hemophilia or skin psoriasis.

Product page: NSS-2 BRIDGE…

Via: FDA…

Editors

At Medgadget, we set of the most recent medical technology news, interview leaders within the field, and file dispatches from medical occasions from around the globe.

ABILIFY MYCITE, The First FDA Approved Digital Medicine That Tracks Its Own Ingestion



Proteus Digital Health, a Redwood City firm, and Otsuka Pharmaceutical of Tokyo, Japan won FDA approval for the world’s first digital pill. The ABILIFY MYCITE (aripiprazole) is a tablet with a tiny sensor embedded in its interior. After the tablet is swallowed and dissolved, the sensor meets the stomach juices, which activate it and allow it to communicate with a patch worn by the patient. The patch transmits its readings to a smartphone or tablet, communicating every time that the pill is swallowed with the patients doctor or caretakers. The tiny ingested sensor is then passed by the GI system and leaves the body.

The first drug to be tracked like this is aripiprazole prescribed for schizophrenia, acute manic and mixed episodes, bipolar I disorder, and major depressive disorder. Because such patients often tend to skip their meds, the new tracking system may help to ensure they stay on track, resulting in optimal therapy and rehabilitation.

Flashbacks: Proteus Pill Ingestion Monitoring System Gets EU Green Light…; Novartis’ Pill Microchip Enables Remote Monitoring of Drug Dosage and Efficacy…; Smart Pill Contains Microchip to Monitor Patients’ Medication…; Proteus Ingestible Sensor for Tracking Medication Intake Receives FDA Clearance…

Via: Proteus…

Editors

At Medgadget, we report on the latest medical technology news, interview leaders in the field, and file dispatches from medical events from around the world.

ABILIFY MYCITE, The First FDA Approved Digital Medicine That Tracks Its Own Ingestion



Proteus Digital Health, a Redwood City firm, and Otsuka Pharmaceutical of Tokyo, Japan won FDA approval for the world’s first digital pill. The ABILIFY MYCITE (aripiprazole) is a tablet with a tiny sensor embedded in its interior. After the tablet is swallowed and dissolved, the sensor meets the stomach juices, which activate it and allow it to communicate with a patch worn by the patient. The patch transmits its readings to a smartphone or tablet, communicating every time that the pill is swallowed with the patients doctor or caretakers. The tiny ingested sensor is then passed by the GI system and leaves the body.

The first drug to be tracked like this is aripiprazole prescribed for schizophrenia, acute manic and mixed episodes, bipolar I disorder, and major depressive disorder. Because such patients often tend to skip their meds, the new tracking system may help to ensure they stay on track, resulting in optimal therapy and rehabilitation.

Flashbacks: Proteus Pill Ingestion Monitoring System Gets EU Green Light…; Novartis’ Pill Microchip Enables Remote Monitoring of Drug Dosage and Efficacy…; Smart Pill Contains Microchip to Monitor Patients’ Medication…; Proteus Ingestible Sensor for Tracking Medication Intake Receives FDA Clearance…

Via: Proteus…

Editors

At Medgadget, we report on the latest medical technology news, interview leaders in the field, and file dispatches from medical events from around the world.

Electrically Stimulating a particular Brain Region using Ultrafine Wires Enhances Memory

Neuroscientists at UCLA have discovered that electrically stimulating a particular part of the brain using ultrafine wires enhances memory in epilepsy patients. When the technique can enhance memory in other patients, it could assist with conditions for example Alzheimer’s.

Our memory naturally declines as we grow older, as well as in conditions for example Alzheimer’s, people can suffer devastating memory impairments. In research conducted recently appearing in journal eLife, neuroscientists allow us a method that can help to enhance memory.

The study team conducted a memory study in epilepsy patients, who already had ultrafine electrodes implanted within their brain, in order to discover the supply of their seizures. However, the electrodes weren’t only in a position to monitor electrical activity within the brain, but tend to also transmit a little electrical current to a particular brain regions.

They monitored the signal in the electrodes as the subjects performed a learning task of studying pictures of faces. A really small current, inside a specific pattern of quick pulses, was sent to the entorhinal part of the brain throughout the learning task, and also the researchers discovered that the topics could better recognize the facial images later, demonstrating their memory was improved.

The process implies that merely a small current is needed to help memory and learning, and in contrast to previous studies where large regions of the mind were stimulated with mixed results, the highly specific and non-invasive technology within this study likely helped. It remains seen when the technique might be exploited for other patients with memory impairments, for example individuals with Alzheimer’s.

Study in eLife: Theta-burst microstimulation within the human entorhinal area improves memory specificity…

Via: UCLA…

Ria Health Launches Mobile Application in lowering Consuming (Interview)

A week ago we shared 12 new companies unveiling their innovative ideas at Health 2.0’s Launch! event this season. During the exhibit hall, a couple of more initial phase companies were also leveraging Health 2. to kickoff new programs and technologies. One of these simple was the state launch of Ria Health‘s mobile application solution to help individuals reduce their consuming through a mix of support from addiction specialists and daily progress tracking. The organization started testing the merchandise captured and, getting seen great initial outcomes, has become making we’ve got the technology open to consumers seeking a brand new method of reduce consuming.

Among the original clinical founders and today Chief Medical Officer of Ria Health, Dr. John Mendelson, is quoted as stating that, “Leading scientific study has developed effective and safe treating excessive drinking, however these treatments haven’t been adopted. Being an worldwide recognized addiction specialist and investigator my team and that i produced Ria Health to create these treatments to everybody.”

The announcement also highlighted adding Tom Nix, former consultant, towards the core Ria Health team as Ceo. While ongoing their objective of realizing an interesting member experience, Tom’s role may also concentrate on the growth and development of proper funnel partnerships within corporate HR, health systems, and also the physician community. Commenting about this chance for enterprise growth, Tom believes that, “Ria Health might help employers offer private, effective choose to their workers with measured outcomes which are positive and cost-effective along with a convenient program you can use within the comfort and privacy that belongs to them home.”  While at Health 2., Medgadget had an opportunity to interact with Tom to find out more.

Medgadget: Where did the concept behind Ria Health originate from?

Tom Nix, Ria Health Chief executive officer

Tom Nix: Our mind of technology, and my buddy, Bob Nix, spent nine years building among the greatest technology platforms in healthcare at athenahealth. While transitioning from that role, he discovered Dr. John Mendelson, who had been operating in the addiction space. Bob was convinced within the effectiveness of Dr. Mendelson’s work and also the numerous Food and drug administration studies that demonstrated the advantages of addiction-related education. Because he began searching to have an initial use situation, Bob started to consider the difficulties and impact of consuming. The Nation’s Institute on Excessive Drinking and Alcoholism estimates that about 34 million individuals the U . s . States are afflicted by Alcohol Consumption Disorder By having an chance to deal with what could effectively certainly be a chronic illness, he felt it might be an essential need that the new solution might be introduced to promote to deal with.

Medgadget: Do you know the challenges of traditional methods to managing consuming?

Tom: Solutions happen to be attempted before but they’re frequently standalone medical, social, or technology-driven approaches. Traditional treatment methods are typically rehab or Aa (AA). They are two great options, however they don’t always fit exactly what the individual needs. Residential rehab lasts 4 weeks which may be very disruptive to daily existence since you need to really focus and disconnect throughout this program. AA is really a strong alternative but you will find people we’ve spoken with who aren’t confident with the religious facet of that group or even the public situation they’re place in despite having the ability to be “anonymous.”

Today, only 4% of people battling with consuming go for these kinds of programs. Clearly we want another solution. More lately, using the development of digital health, application-only solutions will be in this mixture. However, by having an application-only method, you miss the chance to supply individuals with true, significant, objective measures while connecting all of them with an assistance network simultaneously.

Medgadget: Exactly what does Ria Health do differently?

Tom: At Ria Health, we combine all multiple of those elements into one solution including certified telemedicine coaches, drink tracking and breath analyzer data, along with a social capacity to interact having a personal support included in the process. To provide you with a bit more detail, our certified coaches use people to put together strategies, plans, and goals in lowering or stop consuming. Many people tend from physician support since it may be very costly. However, there’s evidence to exhibit that whenever a health care provider is engaged, individuals tackling consuming challenges are more inclined to be concerned a bit longer of your time than programs without it element. Used, we all do observe that telemedicine sessions are really extremely popular since, anecdotally, individuals are more prepared to be obvious within their problems and supply more detail regarding their needs once they feel like maintaining their privacy, dignity, and there’s no shame or stigma that could be associated with classical consuming programs.

Documenting the amount of drinks and recording breath analyzer data assistance to evaluate how people do with time and supply metrics for progress towards each member’s goals. Users can invite anybody, just like a family or friend, right into a private social networking to sign up within their journey towards controlling their consuming habit. The social capacity derives, partly from what AA was achieving once they started within the 1903s. Basically we possess the capacity to permit member-to-member socialization, we have to be cautious to understand if this sounds like something our people want or maybe focusing interactions between your member, their coach, as well as their private social networking is so far as we ought to go.

The mixture of all of these features leads to people dramatically reducing their consuming and sustaining their participation within the program with time. Today, we’ve 4 patents pending around our approach and procedures.

Medgadget: You mention tracking progress. Do users eventually finish this program or transition into using Ria in different ways because they achieve their objectives?

Tom: Most behavior change for individuals managing their consuming happens within 12 several weeks. Included in the initial increase, people define their success criteria. For other individuals available, the aim is frequently abstinence. Something to become obvious about here’s that at Ria Health, we’re not requesting abstinence. People ought to set their very own, personal objectives and goals which may be any place in the plethora of reducing to stopping consuming altogether. Members’ motivations to scale back on consuming also influence their set goals and will include slimming down, better sleep, and getting better relationships. All of these are negative effects of consuming less often and therefore are essential for the member to acknowledge when figuring out what they’re searching to get away from this program.

Many people hit their success criteria earlier than others but have the ability to possibilities to carry on maintaining that success or using the program even more beyond their initial goals. Therefore we have graduates who achieve their objectives and finish this program. We have people using Ria Health like a maintenance program after they achieve their set goals by ongoing to trace their activity and interesting within the social media area of the technology to help keep themselves accountable.

Medgadget: Ria Health is formally launching today for consumers.

Tom: We intentionally launched having a direct-to-consumer model which, to the enjoyable surprise, resulted in we could rapidly begin growing our member base and immediately begin helping a lot of people. We did this individually distinct, before official launch, captured in The month of january. The advantage of this tactic is the fact that our initial people happen to be supplying insights into the way they make use of the system which will help us boost the consumer experience to higher improve our technology. Instead of awaiting a Business to business pilot, this method permitted us to obtain data from users faster. Already, we’re seeing typically 30 interactions per member monthly and also have documented over 16,000 member interactions up to now by having an expectation of doubling that to in excess of 30,000 over the following thirty days. The quantity of data we’re mining and making use of to enhance we’ve got the technology is going to be far more than any competitor entering this space. Once we start to build out our enterprise relationships, we can sit lower with health systems and providers and show real, significant outcomes from actual people.

Medgadget: Out of your initial group of data, whoever else discovered your people and also have you started to realize any one of individuals outcomes you pointed out?

Tom: At this time, our membership is all about 60% ladies and 40% men by having an average chronilogical age of 45 years. What’s really exciting though is the fact that our initial cohort of test people decreased their drinking typically 60% within the first thirty days. I’m able to really demonstrate a graph in our consumption with time data from people of Ria Health [see below].  Coming up, we’re intending to show more data, leveraging our user data and existing financial savings analyses using their company consuming reduction programs, about how helping our people reduce consuming also generates an essential roi for employers along with other healthcare organizations who we’re excited to start dealing with to deal with this critical need.

4 months of progress achieved by Ria Health people. All customer information is averaged within this chart showing daily bloodstream alcohol concentration (BAC) when compared with baseline BAC measured at the beginning of this program. Raw member information is smoothed having a 7-day moving average, and every reason for the chart shows the typical across all people tomorrow.

Link: Ria Health…

Health 2. Fall Conference: SleepTech Summit Exhibit Hall Companies

A distinctive track only at that year’s Health 2. Fall Conference is really a SleepTech Summit concentrating on innovations that enhance or improve an individual’s capability to acquire a faster, longer, and much more refreshing sleep. Included in the primary exhibit hall, six sleep-related companies were demoing their devices and technologies, and Medgadget had an opportunity to hold short interviews with every one.
Additionally to those six technology companies, Sleep-Geek seemed to be attending. Sleep-Geek is really a website an internet-based community founded this year having a pursuit to serve the bed mattress industry by connecting people with ideas that provide their professional goals. Operated by Leggett & Platt, Sleep-Geek believes that sleep industry professionals should take time to be sleep consultants for their clients by counseling them on their own sleep and well-being.
Now to the interviews!

Medgadget: Which of ASTI’s technology is you showing at Health 2.?

Stacey Pinneke, Director of promoting and Communications, Adaptive Seem Technology, Corporation (ASTI): We have many devices here such as the LectraFan, LectroFan micro, and ASTI’s original Seem+Sleep and Seem+Sleep SE devices. Lots of people already go to sleep while hearing their fan or television, which produce a white-colored noise background seem. However, these causes of seem may not be consistent. Lectro Fan, an Amazon . com best-selling product, produces consistent white-colored noise the user can concentrate on without distraction to be able to go to sleep. The unit includes 10 fan sounds and 10 general white-colored noise seem options, along with the capability to modulate seem volume. A built-in timer enables the consumer to instantly switch off the seem once they go to sleep. Made with a significantly smaller sized form factor, the wireless LectroFan micro is really a travel-ready, Bluetooth-enabled form of the LectroFan with four fan sounds, four white-colored noise sounds, and 2 sea sounds. Our original Seem+Sleep devices provide a wider range as high as 64 distinct seem profiles made to promote much deeper sleep, relaxation, and renewal.

Medgadget: Why is ASTI’s technology unique?

Stacey: Two patented features make ASTI’s devices stick out using their company sleep technologies. First, which is essential we place it in the organization name, is the opportunity to generate adaptive seem. Most sleep technologies that generate seem achieve this with looping meaning the seem track eventually reaches an endpoint and needs to be restarted. While may possibly not continually be simple to catch, a person’s subconscious can detect this repetition. Generating adaptive seem implies that ASTI’s technology can combine the large amount of sounds our team is going and recorded and mix them diversely to write tracks in tangible-time that never loop.

Second, our products are constantly using feedback in the atmosphere to modulate the seem they’re emitting inside a responsive manner. For instance, if there’s a loud seem outdoors your living space, ASTI’s devices can raise their volume to keep the user’s ability to pay attention to the seem that’s helping them go to sleep.


Medgadget: What’s Tanda and how’s it going innovating on bed mattress technology?

Brandon Thomas, Communications, Tanda: Tanda is really a new bed mattress visiting the marketplace now! The name, Tanda, means “cool” in Hindi and it is connected using the low-tech cooling capacity built directly into the bed mattress that enables the consumer to possess a better night’s sleep. Research has proven the cooler your body happens when trying to go to sleep, the faster it may go to sleep. Tanda incorporates Atros, a cooling cover produced from fibers that pull awesome air in the room and onto the top bed mattress. When lounging around the bed mattress, the top remains in a cooler temperature for around 15-20 minutes, that is about how exactly lengthy it requires to go to sleep. Users are suggested to rest on Tanda in rooms having a temperature between 65 and 72 levels F for optimal results. Tanda is ideal for individuals who constantly feel warm when attempting to go to sleep and who awaken sweaty in the center of the night time.

Presently, Tanda offers two versions in our bed mattress: Comfy Awesome, which supplies an easy cooling sensation and contains a comfortable, breathable foam, and finish Awesome, which includes the entire Atros system. Approaching at the start of 2018, we’re excited to become launching something new centered on the couple’s experience. Should you sleep one of the ways as well as your partner sleeps another, our cool product allows variability that lets both of these individuals have a comfortable, awesome night’s sleep.

Atros system pulls air in the room (blue) as the body emits heat and triggers cooling.

Medgadget: Bed mattress technologies are getting good popular lately. How can you begin to see the competitive space where Tanda positions itself?

Brandon: The competitive space, with the likes of Casper, has lately been based on the evolution of internet, direct-to-consumer, bed mattress-in-a-box solutions which have revolutionized the acquisition and delivery process. At Tanda, we all do that although also innovating around the sleep experience and being thoughtful concerning the health facets of sleep. Not one other competitor does what we should are today when it comes to our features like our Opti-Breeze foam and Atros technology. There’s also other bed mattress products starting to incorporate more sensors and IOT abilities to their bed mattress products. Tanda believes that low-tech is essential in allowing the bed mattress to complete everything for you personally, away from the box. A year considerable time in the last summer time with focus groups across all genres of shoppers from millennials to grandma and grandpa, singles and couples. We feel Tanda is providing the best product for which individuals are requesting in bed mattress technology today.


Medgadget: Are you able to provide us with an introduction to the Nightingale technology? (Note: Medgadget reviewed the Nightingale system captured)

Tim Suri, Director of Funnel Sales, Cambridge Seem Management: Nightingale is a great home sleep system produced by Cambridge Seem Management, the biggest seem technology company on the planet. Most seem control technology is essentially white-colored noise generating devices which make a hissing seem to drown out conversations. Our founder was an Durch innovator having a PhD in acoustics who centered on human hearing and speech frequencies that are now patented included in our seem masking technology. Finances had our technology being used through the government, answering services company, and office structures for more than twenty years. Nightingale is our first consumer product by which we have seen an enormous chance to consider this seem technology which help them achieve better sleep.
Nightingale is Wireless and Bluetooth-enabled, IOT friendly, and works directly with Apple home and Alexa technologies. Built in to a device that sits right more than a standard wall plug if you don’t take up either outlet, Nightingale has 15 preset frequencies that modulate to every room’s acoustics and also the user’s sleep conditions. A few examples of those preset frequencies that we understand are essential use cases for consumers include: seem blanket, snoring blanket, tinnitus, infant, elderly care, and hospital.
One device covers 150 square ft and 2 units can achieve from 300-400 square ft. Nightingale is due the customer in Canada in a few days through resellers like Brookstone, Sam’s Club, and Lowes.


Medgadget: How can you tell it really works? Are you able to talk about how Nightingale interacts along with other IOT technologies.

Tim: We did a clinical study with Harvard Medical to judge Nightingale’s abilities. What we should found was our technology helped people go to sleep 38% faster and stored them asleep in addition to using roughly two sleep aids.

Nightingale interacts along with other IOT technologies like Nest and Hue devices through Advanced IFTTT. IFTTT is really a free web-based service that enables users to define interactions between other cloud based services and devices. Through this sort of integration, you could have Nightingale trigger from other inputs for example telling you that somebody is in front door.

Medgadget: What’s the THIM ring and just how will it assist me to achieve better sleep? (Note: THIM was created through the same team that produced the Re-Timer device to reset circadian rhythms.)

Ben Olsen, Chief executive officer, THIM: THIM is really a sleep tracking ring that can help you go to sleep by waking you up. The actual way it works is you place the THIM ring on any finger when you attend bed. According to your movement, an accelerometer within the device detects if you have fallen asleep after which, three minutes later, it awakens you! The result may be the repeated experience of dropping off to sleep multiple occasions in a single night which effectively trains the body to go to sleep sooner on subsequent nights.
The science behind THIM is dependant on two peer-reviewed, college trials per reviewed which shown this technique will help you go to sleep half an hour sooner and increases sleep duration by 70 minutes. These studies were particularly conducted on individuals identified as having sleep onset insomnia who have been not able to go to sleep at sleep clinics.

Medgadget: How’s THIM diverse from other sleep sensors and approaches, a few of which utilize wrist-based sensors?

Ben: Finger motion is a lot different plus much more pronounced than wrist movement. What this means is the dataset THIM is evaluating is totally various and more insightful compared to datasets from wrist-based sleep monitors. The way forward for THIM and our ongoing R&D jobs are really centered on working out what additional, new insights we are able to be a consequence of this analyzing this largely untouched dataset.
Another factor to focus on is the fact that THIM’s method of better sleep is totally behavior. We’re training individuals to naturally go to sleep better instead of counting on medications to participate the answer.

Medgadget: Where did the concept for that Smart Pillow originate from and what sort of data will it capture?

Dr. Ron Loose, Inventor from the Proper and Smart Pillows, Proper Pillow: Sleep is probably the most important a part of being healthy. We spent a lot of time creating a pillow that comes with memory foam the perception of better sleep within the Proper Pillow. Following on our original Proper Pillow, we accepted consumer’s curiosity about integrated sensors and IOT technology to produce the Smart Pillow. We consider the pillow like a non-wearable, wearable because it contains a sensor network having the ability to capture pressure, thermal, and audio information while you sleep.

Pressure sensors monitor your movement and really demonstrate a visualized illustration showing your movement throughout the night on the mobile application. For individuals worried about privacy, the audio sensors don’t capture continuous audio but instead record very short audio samples in discrete time increments to look for the current decibel level sometimes points at night time. Mixing the information from all of these two sensors might help users correct behaviors that could be detracting from the good night’s sleep. For instance, when the pillow notices you snore frequently somewhere although not another, it may lightly vibrate whenever you use once side to allow you to switch to an orientation that minimizes snoring.

Medgadget: What else can the consumer do with the Smart Pillow mobile application?

Dr. Ron: With the mobile application, use a quantity of capabilities included in the Smart Pillow. Rather of utilizing a frustrating noisy alarms to awaken, the pillow can lightly vibrate to wake you up more easily. Returning to the problem in which a user is snoring frequently, our favorite features, and something reason partners in our users love the merchandise, may be the snore alert. Your house your lover awakens in the center of the night time since you are snoring. The following day search back in the Smart Pillow’s audio data and find out the decibel degree of your snoring seem whenever you automobile your partner. With the Smart Pillow mobile application, after that you can set a snore alarm threshold below that decibel level. The following night, in case your snoring raises towards the threshold, vibration in the pillow can help you reduce snoring and go back to a great night’s sleep before you decide to otherwise might have woken your lover.

We’ve been talking with Muse for any couple of years. Medgadget last checked along with an up-to-date Muse product review captured.

Medgadget: We’ve been following firm for some time now, what new, exciting things is Muse revealing at Health 2. this season?

Jacqueline Cooper, Executive V . P . of Sales & Marketing, InteraXon: Today, we’re still seeing success helping individuals with addiction, eating, trauma, and Post traumatic stress disorder management, which take advantage of regular meditation. However, one challenge we frequently consider is how you can encourage users to help keep choosing Muse and realize these benefits. An excellent chance we’re really looking forward to is our partnership with Sanfilo to include Muse technology in to the Cruz make of shades. This puts Muse right into a product and form component that users can put on regularly. It makes sense more data taken by Muse technology along with other sensors which are included in in to the Cruz glasses supplying much more possibilities to provide users feedback on better managing their anxiety and stress.

We’re also seeing important growth as providers start to recommend Muse straight to their sufferers. With this thought, another essential advancement which represents an essential evolution within our business design pertains to the deployment of the portal that these providers can manage all of their patients utilizing a Muse device. Studies have shown that feedback is essential to keeping users on the right track using their plan for treatment. With this thought, the woking platform is invaluable to both users as well as their providers who are able to now interact more collaboratively to understand the advantages of Muse technology. We’re also trying to allow providers to obtain ongoing medical education (CME) credits with the Muse portal.

Link: Health 2. Fall Conference…

Phosphorus Launches Diagnostic Ophthalmology and Drug Response Genetic Tests

NEW You are able to, Sept. 13, 2017 /PRNewswire/ — Phosphorus, a computational genomics company, announced today adding two advanced genetic tests to the catalogue: An ophthalmologic test for inherited conditions connected with vision loss and blindness, along with a pharmacogenomic test to look at the effectiveness of numerous drugs for particular patients, based on their genes. The most typical retinal disorder around the ophthalmologic test, retinitis pigmentosa, claims an incidence rate of one in three.5 1000 individuals (Haim, 2002)1, along with other conditions tested exhibiting high incidence rates too. Similarly, genetics also take into account 20-95% of variability as a result of individual drugs (Kalow et al, 1998)2, with 10-20% of adverse drug reactions potentially associated with genetics (Ingelman-Sundberg, 2004)3.

Phosphorus’ new tests range from the very indepth panels of genes in line with the latest advances in research. They’ll be unveiled in the National Society of Genetic Counselors (NSGC) Annual Conference in Columbus, Ohio now.

“For inherited retinal disorders, dna testing may be used to prevent vision loss and blindness,” described Oscar Puig, Chief Scientific Officer at Phosphorus. “Furthermore, our new genetic tests for drug response will equip patients with information about how to higher optimize their medication.”

Phosphorus’ expert-curated panels, effective data analytics, and rigorous variant interpretations happen to be developed and designed to guarantee the most accurate recent results for patients. The exams are operated by next-generation sequencing technology, including comprehensive recognition of copy number variants. The straightforward testing workflow is made to ease the procedure for physicians and supply an inexpensive choice for patients as well as their family people.

“Using the launch in our ophthalmologic and pharmacogenomic tests, we’re expanding our portfolio of diagnostic products, including comprehensive tests in cardiology, oncology, and reproductive health. By pairing these studies with Phosphorus’ Elements software, we provide the very first finish-to-finish solution enabling laboratories and medical facilities to construct and expand their precision medicine abilities,” stated Alexander Bisignano, co-founder and Chief executive officer of Phosphorus.

The recently launched ophthalmology genetic test includes the next conditions:

  • Retinal Disorders: 146 genes. Includes genes connected with achromatopsia, Bardet-Biedl syndrome, cone-fishing rod dystrophy, Usher syndrome, hereditary stationary night blindness, Leber hereditary amaurosis, retinitis pigmentosa, and macular dystrophy.
  • Cataracts: 38 genes. Hereditary cataracts are the most typical reason for treatable childhood blindness, with 25-33% of cases being hereditary4.
  • Glaucoma: 18 genes. Early-onset glaucoma can result from hereditary conditions.
  • Corneal Dystrophy: 8 genes. About one in 1,000 people includes a corneal dystrophy that can result in vision loss after lasek5.

The recently launched drug response genetic test covers probably the most generally prescription drugs across a sizable mix portion of therapeutic areas, including cardiology, psychiatry, oncology, discomfort management, neurology, immunology, gastroenterology, respiratory system, infectious disease, yet others.

Find out more about Phosphorus tests in the National Society of Genetic Counselors Annual Conference in Columbus, Ohio at booth #350. See the company’s research poster presentation, “Obvious Indication for Cardiogenetics Testing Not Good GC Referral Options. How Can Genetic Counselors Think a Cardiologist Should Proceed?,” on Wednesday, September 13, 2017 from 5:15 PM to six:30 PM (poster A-10). See the company’s other research poster presentation, “CDC Tier 1 Genomic Applications: Awareness Among GCs and Potential Effect on GC Practices,” on Friday, September 15, 2017 from 1:15 to two:30 PM (poster C-9). Both presentations is going to be delivered within the exhibit hall.

About Phosphorus

Phosphorus is really a computational genomics company using the vision to produce a world where every healthcare decision is enhanced with genomics. Headquartered in New You are able to City, Phosphorus offers clinical genetic tests in a variety of clinical areas from the CLIA-certified laboratory. The organization also develops effective software that allows labs all over the world to provide probably the most advanced genetic tests. Phosphorus’ active development and research program comes with an initial concentrate on decoding the genetic reasons for infertility and inherited coronary disease. Having a group of experts in computational biology and information technology, Phosphorus is creating a data network that can help providers, researchers and patients all over the world better understand and harness the strength of a persons genome. To learn more visit: world wide web.phosphorus.com and @phosphorus.

1Haim M. Epidemiology of retinitis pigmentosa in Denmark. Acta Ophthalmol Scand Suppl. 2002(233):1-34.
2Kalow W, Tang BK, Endrenyi L. Hypothesis: comparisons of inter- and intra-individual variations can replacement for twin studies in drug research. Pharmacogenetics. 19988(4):283–289.
3Ingelman-Sundberg M. Pharmacogenetics of cytochrome P450 and it is applications in drug therapy: yesteryear, present and future. Trends Pharmacol Sci. 200425(4):193-200.
4Yi J. et al. (2011). Int J Ophthalmol, 4(4), 422-32.
5Lee J. et al. (2010). Ophthalmic Epidemiology, 17(3), 160-165.

View original quite happy with multimedia:http://world wide web.prnewswire.com/news-releases/phosphorus-launches-diagnostic-ophthalmology-and-drug-response-genetic-tests-300518987.html

SOURCE Phosphorus

Related Links

http://phosphorus.com

Virtual Reality Accustomed to Study Origin of Anxiety and stress


Our irrational fears are generally very real and are generally figments in our imagination. By manipulating what we should consider as reality, researchers at Stanford College will work to know the origin in our anxieties and the way to alleviate them. To do so, they built an online reality chamber where one’s fears could be generated with a computer. Back In 1984, it, it was completed in a unique room too, however with real objects of fear as well as for opposite reasons. Anticipation is the fact that by having the ability to induce a condition of fear we are able to better know how are brains are made and just how we elect to act challenging environments.

Here’s video concerning the research revealing a couple of types of we’ve got the technology for action:

More from Stanford Medicine: The fearful eye…

Via: SCOPE blog…

Editors

At Medgadget, we set of the most recent medical technology news, interview leaders within the field, and file dispatches from medical occasions from around the globe.

Neuropace Epileptic Seizure Control System: Interview with Dr. Martha Morrell, CMO of NeuroPace

Individuals with certain kinds of epilepsy may can make use of a therapy that does not include drugs. The RNS system from Neuropace, a business from Mountain View, California, monitors the mind for indications of an oncoming seizure and stimulates it to disrupt the procedure. It’s been approved within the U.S. for around 4 years now, so we desired to find much more about how it operates and just how it’s getting used. We’d an opportunity to speak with Dr. Martha Morrell, Chief Medical Officer of NeuroPace, who had been kind enough to reply to our questions.

Medgadget: The NeuroPace RNS system has proven to work at reducing seizures in lots of patients with epilepsy. Are you able to provide us with a short summary of the way the system functions?

Dr. Martha Morrell: The RNS Product is the world’s first and just medical device that may monitor and react to brain activity instantly, stopping epileptic seizures in their source. It’s Food and drug administration approved for people aged 18 and older who’ve attempted a minimum of 2 antiseizure medications but nonetheless are afflicted by frequent and disabling partial onset seizures which come from a couple of regions of the mind. The RNS Product is a little, implantable device linked to leads which are put into as much as two seizure onset areas. The unit continuously monitors brain activity, detects abnormal patterns, as well as in response delivers imperceptible electrical pulses to normalize the game before a person encounters seizures. The RNS Product is the only real epilepsy therapy which provides physicians clinically significant ongoing data regarding their patients’ seizure frequency and electrocorticographic activity. The individual utilizes a simple remote monitor in your own home to wirelessly collect and upload data in the neurostimulator. The information is distributed around the patient’s physician to examine and evaluate to personalize and improve patient care.

Medgadget: The system continues to be authorized by the Food and drug administration for any couple of years. How good has it been adopted in clinical practice? Have you ever become a feeling of exactly what the overall patient experience continues to be?

Dr. Morrell: The RNS System received Food and drug administration approval in November 2013. The RNS System represents a paradigm transfer of how patients with partial refractory epilepsy might be treated. Over 1,300 patients have obtained the RNS System so far. Data in the NeuroPace Lengthy Term Treatment trial indicate an average seizure frequency decrease in 72% at many years, 30% of patients having a >90% seizure frequency reduction. In addition, 15% of patients happen to be seizure free for a number of one year periods. Almost all adult comprehensive epilepsy centers provide the RNS System which is broadly included in private and government insurance.

Medgadget: Since NeuroPace’s RNS system doesn’t benefit everybody equally, whoever else found that may improve the way the product is used, applied, or selected for various patients?

Dr. Morrell: NeuroPace is applying deep learning strategies to evaluate over a million segments of brain electrical activity growing insights in to the brain and optimize patients’ results using the RNS System. We feel the programming for that RNS System continuously improve once we find out more.

Medgadget: Are new items within the works at NeuroPace? Are you able to provide us with any concept of what the organization is focusing on nowadays?

Dr. Morrell: In accessory for treating epilepsy, responsive neurostimulation holds the potential of treating a number of other nerve disorders that impact the caliber of existence for countless patients all over the world. Patients using the RNS System have previously proven a statistically significant improvement in memory and cognition, that leads us to think the RNS System can treat numerous additional nerve disorders.

Medgadget: Please inform us concerning the company’s background and the way it could develop and commercialize such innovative and hard introducing technology?

Dr. Morrell: The initial concept for that RNS System technology came into being within the late 1990s. Chief executive officer Frank Fischer plus a number of medical device inventors, engineers, and physicians for example Dr. Martha Morrell developed the idea of expanding pacemaker/defibrillator technology to sense brain activity and react to the game it detected. Since there wasn’t any existing data on technology such as this, Fischer’s colleagues began on your own, analyzing tapes of electrocardiographs from patients. Following 14 many years of a rigorous development and research, and 2 numerous studies that produced good results, the RNS System received Food and drug administration approval. Commercializing and raising awareness round the RNS Product is challenging because the RNS System would be a completely new kind of technology. NeuroPace is positively educating physicians, healthcare practitioners, patients and caregivers about the advantages of moving perfectly into a paradigm where responsive neurostimulation is the grade of take care of treating patients with medically out of control partial onset seizures.

Medgadget: What regarding your experience in this subject and also at NeuroPace particularly? What are the challenges and rewards that you simply found intriguing and essential in your job?

Dr. Morrell: What we’ve accomplished at NeuroPace holds true translational research—we’ve taken an idea in the bench and developed it right into a treatment that’s alleviating the suffering of patients with medically out of control seizures. Personally, I could go ahead and take understanding and experience I’d acquired within my full-time career in academic neurology and produce it right into a company created develop and generate a completely innovative therapy. Being an academic, I’d not fully appreciated how terribly hard that’s to complete. The tremendous team at NeuroPace produced a really innovative therapy which has transformed the lives of numerous individuals with epilepsy. I begin to see the impact from the RNS System around the patients who took part in the rigorous numerous studies, and today it within the patients I’m treating using the RNS System within my own practice. Being a member of NeuroPace is a rare privilege.

Product page: RNS System…

Flashbacks: NeuroPace: Maybe First Since Jesus to avoid and Treat Epilepsy… NeuroPace Will get Food and drug administration Pre-Market Approval for RNS Stimulator… NeuroPace Seeks Food and drug administration Approval because of its RNS System… Neuropace Implantable Epilepsy Device Showing Positive Signs in Initial Clinical Study…